设为首页 加入收藏

TOP

ACTEMRA(tocilizumab) injection(四十)
2017-05-24 01:00:21 来源: 作者: 【 】 浏览:20550次 评论:0
011) tocilizumab 20 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
sucrose (UNII: C151H8M554) 
polysorbate 80 (UNII: 6OZP39ZG8H) 
SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE (UNII: E1W4N241FO) 
sodium phosphate, monobasic, dihydrate (UNII: 5QWK665956) 
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:50242-137-01 1 in 1 BOX 01/08/2010 
1  20 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125276 01/08/2010 
ACTEMRA 
tocilizumab injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50242-138
Route of Administration SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
tocilizumab (UNII: I031V2H011) (tocilizumab - UNII:I031V2H011) tocilizumab 180 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
polysorbate 80 (UNII: 6OZP39ZG8H) 
histidine (UNII: 4QD397987E) 
histidine monohydrochloride monohydrate (UNII: X573657P6P) 
arginine (UNII: 94ZLA3W45F) 
arginine hydrochloride (UNII: F7LTH1E20Y) 
methionine (UNII: AE28F7PNPL) 
water (UNII: 059QF0KO0R) 
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:50242-138-01 1 in 1 BOX 10/21/2013 
1  0.9 mL in 1 SYRINGE, GLASS; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)  
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125472 10/21/2013 
LABELER - GENENTECH, INC. (080129000)
REGISTRANT - GENENTECH, INC. (080129000)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Roche Pharma AG  315009878 ANALYSIS(50242-135, 50242-136, 50242-137, 50242-138)
ESTABLISHMENT
Name Address ID/FEI Business Operations
F. Hoffmann-La Roche Ltd  485244961 LABEL(50242-138) , ANALYSIS(50242-138)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Genentech, Inc. (Oceanside)  146373191 ANALYSIS(50242-135, 50242-136, 50242-137, 50242-138) , API MANUFACTURE(50242-135, 50242-136, 50242-137, 50242-138)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Genentech, Inc. (SSF)  080129000 ANALYSIS(50242-135, 50242-136, 50242-137) , MANUFACTURE(50242-135, 50242-136, 50242-137)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Roche Diagnostics GmbH  315028860 ANALYSIS(50242-135, 50242-136, 50242-137)
ESTABLISHMENT
Name Address ID/FEI Business Operations
Genentech, Inc. (Vacaville)  004074162 ANALYSIS(502
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 37 38 39 40 41 下一页 尾页 40/41/41
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇TYMLOS™ (abaloparatide) i.. 下一篇TRAMADOL HYDROCHLORIDE

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位